Cargando…

Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? – A Systematic Review of Structural and Functional Brain Abnormalities

INTRODUCTION: Pre-psychotic and early psychotic characteristics are investigated in the high-risk (HR) populations for psychosis. There are two different approaches based either on hereditary factors (genetic high risk, G-HR) or on the clinically manifested symptoms (clinical high risk, C-HR). Commo...

Descripción completa

Detalles Bibliográficos
Autores principales: Smieskova, R, Marmy, J, Schmidt, A, Bendfeldt, K, Riecher-Rössler, A, Walter, M, Lang, UE, Borgwardt, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580804/
https://www.ncbi.nlm.nih.gov/pubmed/23157639
http://dx.doi.org/10.2174/0929867311320030018
_version_ 1782260331356094464
author Smieskova, R
Marmy, J
Schmidt, A
Bendfeldt, K
Riecher-Rössler, A
Walter, M
Lang, UE
Borgwardt, S
author_facet Smieskova, R
Marmy, J
Schmidt, A
Bendfeldt, K
Riecher-Rössler, A
Walter, M
Lang, UE
Borgwardt, S
author_sort Smieskova, R
collection PubMed
description INTRODUCTION: Pre-psychotic and early psychotic characteristics are investigated in the high-risk (HR) populations for psychosis. There are two different approaches based either on hereditary factors (genetic high risk, G-HR) or on the clinically manifested symptoms (clinical high risk, C-HR). Common features are an increased risk for development of psychosis and similar cognitive as well as structural and functional brain abnormalities. METHODS: We reviewed the existing literature on longitudinal structural, and on functional imaging studies, which included G-HR and/or C-HR individuals for psychosis, healthy controls (HC) and/or first episode of psychosis (FEP) or schizophrenia patients (SCZ). RESULTS: With respect to structural brain abnormalities, vulnerability to psychosis was associated with deficits in frontal, temporal, and cingulate regions in HR, with additional insular and caudate deficits in C-HR population. Furthermore, C-HR had progressive prefrontal deficits related to the transition to psychosis. With respect to functional brain abnormalities, vulnerability to psychosis was associated with prefrontal, cingulate and middle temporal abnormalities in HR, with additional parietal, superior temporal, and insular abnormalities in C-HR population. Transition-to-psychosis related differences emphasized prefrontal, hippocampal and striatal components, more often detectable in C-HR population. Multimodal studies directly associated psychotic symptoms displayed in altered prefrontal and hippocampal activations with striatal dopamine and thalamic glutamate functions. CONCLUSION: There is an evidence for similar structural and functional brain abnormalities within the whole HR population, with more pronounced deficits in the C-HR population. The most consistent evidence for abnormality in the prefrontal cortex reported in structural, functional and multimodal studies of HR population may underlie the complexity of higher cognitive functions that are impaired during HR mental state for psychosis.
format Online
Article
Text
id pubmed-3580804
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-35808042013-03-04 Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? – A Systematic Review of Structural and Functional Brain Abnormalities Smieskova, R Marmy, J Schmidt, A Bendfeldt, K Riecher-Rössler, A Walter, M Lang, UE Borgwardt, S Curr Med Chem Article INTRODUCTION: Pre-psychotic and early psychotic characteristics are investigated in the high-risk (HR) populations for psychosis. There are two different approaches based either on hereditary factors (genetic high risk, G-HR) or on the clinically manifested symptoms (clinical high risk, C-HR). Common features are an increased risk for development of psychosis and similar cognitive as well as structural and functional brain abnormalities. METHODS: We reviewed the existing literature on longitudinal structural, and on functional imaging studies, which included G-HR and/or C-HR individuals for psychosis, healthy controls (HC) and/or first episode of psychosis (FEP) or schizophrenia patients (SCZ). RESULTS: With respect to structural brain abnormalities, vulnerability to psychosis was associated with deficits in frontal, temporal, and cingulate regions in HR, with additional insular and caudate deficits in C-HR population. Furthermore, C-HR had progressive prefrontal deficits related to the transition to psychosis. With respect to functional brain abnormalities, vulnerability to psychosis was associated with prefrontal, cingulate and middle temporal abnormalities in HR, with additional parietal, superior temporal, and insular abnormalities in C-HR population. Transition-to-psychosis related differences emphasized prefrontal, hippocampal and striatal components, more often detectable in C-HR population. Multimodal studies directly associated psychotic symptoms displayed in altered prefrontal and hippocampal activations with striatal dopamine and thalamic glutamate functions. CONCLUSION: There is an evidence for similar structural and functional brain abnormalities within the whole HR population, with more pronounced deficits in the C-HR population. The most consistent evidence for abnormality in the prefrontal cortex reported in structural, functional and multimodal studies of HR population may underlie the complexity of higher cognitive functions that are impaired during HR mental state for psychosis. Bentham Science Publishers 2013-01 2013-01 /pmc/articles/PMC3580804/ /pubmed/23157639 http://dx.doi.org/10.2174/0929867311320030018 Text en © 2013 Bentham Science Publishers http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Smieskova, R
Marmy, J
Schmidt, A
Bendfeldt, K
Riecher-Rössler, A
Walter, M
Lang, UE
Borgwardt, S
Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? – A Systematic Review of Structural and Functional Brain Abnormalities
title Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? – A Systematic Review of Structural and Functional Brain Abnormalities
title_full Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? – A Systematic Review of Structural and Functional Brain Abnormalities
title_fullStr Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? – A Systematic Review of Structural and Functional Brain Abnormalities
title_full_unstemmed Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? – A Systematic Review of Structural and Functional Brain Abnormalities
title_short Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? – A Systematic Review of Structural and Functional Brain Abnormalities
title_sort do subjects at clinical high risk for psychosis differ from those with a genetic high risk? – a systematic review of structural and functional brain abnormalities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580804/
https://www.ncbi.nlm.nih.gov/pubmed/23157639
http://dx.doi.org/10.2174/0929867311320030018
work_keys_str_mv AT smieskovar dosubjectsatclinicalhighriskforpsychosisdifferfromthosewithagenetichighriskasystematicreviewofstructuralandfunctionalbrainabnormalities
AT marmyj dosubjectsatclinicalhighriskforpsychosisdifferfromthosewithagenetichighriskasystematicreviewofstructuralandfunctionalbrainabnormalities
AT schmidta dosubjectsatclinicalhighriskforpsychosisdifferfromthosewithagenetichighriskasystematicreviewofstructuralandfunctionalbrainabnormalities
AT bendfeldtk dosubjectsatclinicalhighriskforpsychosisdifferfromthosewithagenetichighriskasystematicreviewofstructuralandfunctionalbrainabnormalities
AT riecherrosslera dosubjectsatclinicalhighriskforpsychosisdifferfromthosewithagenetichighriskasystematicreviewofstructuralandfunctionalbrainabnormalities
AT walterm dosubjectsatclinicalhighriskforpsychosisdifferfromthosewithagenetichighriskasystematicreviewofstructuralandfunctionalbrainabnormalities
AT langue dosubjectsatclinicalhighriskforpsychosisdifferfromthosewithagenetichighriskasystematicreviewofstructuralandfunctionalbrainabnormalities
AT borgwardts dosubjectsatclinicalhighriskforpsychosisdifferfromthosewithagenetichighriskasystematicreviewofstructuralandfunctionalbrainabnormalities